He specializes in the preparation and prosecution of patent applications in the areas of life sciences, molecular biology, biotechnology, stem cell technology and protein engineering. Kian Hoe graduated from the Imperial College London in Biochemistry and completed his postgraduate studies at the University of Cambridge with a PhD in Protein Engineering. He was funded by the National Science (BS-PhD) Scholarship from the Agency for Science, Technology and Research (A*STAR) for his studies. Kian Hoe was also a research fellow at the p53lab, A*STAR, where he worked on understanding the mechanisms of drug–induced apoptosis in acute myeloid leukaemia. He was also concurrently involved in a number of antibody development projects.